Company JW (Cayman) Therapeutics Co. Ltd
Equities
2126
KYG5210T1040
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 HKD | +1.74% | +2.34% | -22.57% |
Mar. 20 | JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023 | MT |
Mar. 20 | JW Therapeutics Co. Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 398
Sales per Business
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Anti-tumor Drugs
100.0
%
| 37 | 100.0 % | 169 | 100.0 % | +356.49% |
Sales per region
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 37 | 100.0 % | 169 | 100.0 % | +356.49% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yi Ping Li
CEO | Chief Executive Officer | 59 | 17-09-05 |
Chief Tech/Sci/R&D Officer | 43 | 22-01-09 | |
Mark Gilbert
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Hong Xia Zheng
PRN | Corporate Officer/Principal | 55 | 19-02-17 |
Ka Man Ng
SEC | Corporate Secretary | - | 21-12-16 |
Corporate Officer/Principal | 56 | 22-01-09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Debra Yu
BRD | Director/Board Member | 59 | 23-02-28 |
Cheng Liu
BRD | Director/Board Member | 57 | 20-06-29 |
Yi Ping Li
CEO | Chief Executive Officer | 59 | 17-09-05 |
Kin Cheong Ho
BRD | Director/Board Member | 56 | 20-10-21 |
Yiu Leung Cheung
BRD | Director/Board Member | 64 | 20-10-21 |
- | - | ||
Ann Li Lee
BRD | Director/Board Member | 63 | 20-05-21 |
Xing Gao
BRD | Director/Board Member | 39 | 20-05-21 |
Director/Board Member | 46 | 19-11-19 | |
Sung Won Song
BRD | Director/Board Member | 43 | 23-08-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 414,358,958 | 316,073,890 ( 76.28 %) | 0 | 76.28 % |
Company contact information
JW (Cayman) Therapeutics Co. Ltd.
Building B No. 699 Zhong Ke Road
200120, Shanghai
+
http://www.jwtherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.57% | 88.61M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.02% | 22.2B | |
-16.53% | 21.23B | |
-8.61% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- 2126 Stock
- Company JW (Cayman) Therapeutics Co. Ltd